CSIMarket



China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 
 

CBPO's Operating Income Growth by Quarter and Year

China Biologic Products Holdings Inc 's Operating Income results by quarter and year




CBPO Operating Income (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter December 163.65 146.17 135.86 23.26
III Quarter September - - - 39.72
II Quarter June - - 39.40 43.04
I Quarter March - - 38.82 37.89
FY   163.65 146.17 214.08 143.91



CBPO Operating Income forth quarter 2019 Y/Y Growth Comment
China Biologic Products Holdings Inc reported Operating Income increase of 11.96% year on year in the forth quarter 2019, to $ 163.65 millions, this is lower than China Biologic Products Holdings Inc 's recent average Operating Income improvement of 20.76%.

Looking into forth quarter 2019 results within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Operating Income growth. While China Biologic Products Holdings Inc ' s Operating Income growth of 11.96% ranks overall at the positon no. 941 in the forth quarter 2019.

Explain Operating Income growth


CBPO Operating Income ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter December 11.96 % 7.59 % 484.09 % 3.06 %
III Quarter September - - - 13.39 %
II Quarter June - - -8.46 % 6.96 %
I Quarter March - - 2.45 % 9.04 %
FY   11.96 % -31.72 % 48.76 % 8.54 %

Financial Statements
China Biologic Products Holdings Inc 's forth quarter 2019 Operating Income $ 163.65 millions CBPO's Income Statement
China Biologic Products Holdings Inc 's forth quarter 2018 Operating Income $ 146.17 millions Quarterly CBPO's Income Statement
New: More CBPO's historic Operating Income Growth >>


CBPO Operating Income (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter December - - - -41.44 %
III Quarter September - - - -7.71 %
II Quarter June - - 1.49 % 13.59 %
I Quarter March - - 66.9 % 67.88 %
FY (Year on Year)   11.96 % -31.72 % 48.76 % 8.54 %




Operating Income forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #74
Overall #941

Operating Income Y/Y Growth Statistics
High Average Low
484.01 % 20.76 % -100 %
(Dec 31 2017)   0
Operating Income forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #74
Overall #941
Operating Income Y/Y Growth Statistics
High Average Low
484.01 % 20.76 % -100 %
(Dec 31 2017)   0

Operating Income by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

China Biologic Products Holdings Inc 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
124.26 % -1.87 % -100 %
(Mar 31 2014)  


CBPO's IV. Quarter Q/Q Operating Income Comment


Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #0
Operating Income Q/Q Growth Statistics
High Average Low
124.26 % -1.87 % -100 %
(Mar 31 2014)  


CBPO's IV. Quarter Q/Q Operating Income Comment


China Biologic Products Holdings Inc 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Dec 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Dec 31 2017)
12 Months Ending
(Jun 30 2017)
12 Months Ending
(Mar 31 2017)
Cumulative Operating Income 12 Months Ending $ 163.65 $ 146.17 $ 135.86 $ 141.20 $ 144.84
Y / Y Operating Income Growth (TTM) 11.96 % 7.59 % 484.01 % 1.93 % 6.71 %
Year on Year Operating Income Growth Overall Ranking # 969 # 0 # 0 # 0 # 1167
Seqeuential Operating Income Change (TTM) 11.96 % 7.59 % 484.01 % -2.51 % 0.64 %
Seq. Operating Income Growth (TTM) Overall Ranking # 656 # 0 # 0 # 0 # 656




Cumulative Operating Income growth Comment
Although China Biologic Products Holdings Inc 's Annual Operating Income growth year on year were below company's average 42.26% , Operating Income announced in the Dec 31 2019 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 11.96% year on year, from 7.59% in Dec 31 2018.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 0 to 969.

Operating Income TTM Q/Q Growth Statistics
High Average Low
484.01 %
30.68 %
-2.51 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 77
Overall # 969

Operating Income TTM Y/Y Growth Statistics
High Average Low
484.01 %
42.26 %
1.93 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 52
S&P 500 # 656
Cumulative Operating Income growth Comment
Although China Biologic Products Holdings Inc 's Annual Operating Income growth year on year were below company's average 42.26% , Operating Income announced in the Dec 31 2019 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 11.96% year on year, from 7.59% in Dec 31 2018.

In the Healthcare sector 76 other companies have achieved higher trailing twelve month Operating Income growth. While Operating Income growth total ranking has deteriorated compare to previous quarter from 0 to 969.

Operating Income TTM Q/Q Growth Statistics
High Average Low
484.01 %
30.68 %
-2.51 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 8
Healthcare Sector # 77
Overall # 969

Operating Income TTM Y/Y Growth Statistics
High Average Low
484.01 %
42.26 %
1.93 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 52
S&P 500 # 656




Other Operating Income Growth
Biotechnology & Pharmaceuticals Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
CBPO's Operating Income Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for CBPO's Competitors
Operating Income Growth for China Biologic Products Holdings Inc 's Suppliers
Operating Income Growth for CBPO's Customers

You may also want to know
CBPO's Annual Growth Rates CBPO's Profitability Ratios CBPO's Asset Turnover Ratio CBPO's Dividend Growth
CBPO's Roe CBPO's Valuation Ratios CBPO's Financial Strength Ratios CBPO's Dividend Payout Ratio
CBPO's Roa CBPO's Inventory Turnover Ratio CBPO's Growth Rates CBPO's Dividend Comparisons



Companies with similar Operating Income growth for the quarter ending Dec 31 2019 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Dec 31 2019
Intuitive Surgical Inc.19.76%$ 19.759 millions
Davita Inc.19.25%$ 19.252 millions
Abbott Laboratories19.23%$ 19.227 millions
West Pharmaceutical Services Inc.18.69%$ 18.693 millions
Hanger inc.18.14%$ 18.137 millions
Medpace Holdings Inc.17.78%$ 17.779 millions
American Shared Hospital Services17.23%$ 17.227 millions
Icon Plc16.08%$ 16.084 millions
Incyte Corp15.90%$ 15.899 millions
Zoetis Inc.15.31%$ 15.311 millions
Chemed Corporation14.95%$ 14.946 millions
Amedisys Inc14.11%$ 14.110 millions
Tenet Healthcare Corp13.86%$ 13.861 millions
Catalent Inc.13.81%$ 13.811 millions
Abiomed Inc.12.68%$ 12.676 millions
China Biologic Products Holdings Inc 11.96%$ 11.955 millions
Bruker Corporation11.78%$ 11.776 millions
Insulet Corporation11.67%$ 11.674 millions
Stryker Corp11.45%$ 11.452 millions
Hill rom Holdings Inc 11.44%$ 11.441 millions
Novartis Ag11.23%$ 11.225 millions
Bio techne Corp10.09%$ 10.085 millions
Redhill Biopharma Ltd 9.84%$ 9.840 millions
Utah Medical Products Inc9.63%$ 9.630 millions
Laboratory Corporation Of America Holdings9.33%$ 9.327 millions
Henry Schein Inc.9.30%$ 9.296 millions
Teleflex Incorporated6.43%$ 6.428 millions
Charles River Laboratories International inc.6.15%$ 6.154 millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

NHMD's Profile

Stock Price

NHMD's Financials

Business Description

Fundamentals

Charts & Quotes

NHMD's News

Suppliers

NHMD's Competitors

Customers & Markets

Economic Indicators

NHMD's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071